Consumer Industry Roundup: Catalent Acquires Accucaps; CHPA Adds Lobbyist; Zeasorb Recall
Executive Summary
Mylan's Schloss joins CHPA government affairs; Catalent expands softgel capabilities with Accucaps acquisition; GKSk recalls a half million bottles of mislabeled Zeasorb; and more news in brief.
You may also be interested in...
Moberg Adds DermoPlast Line With Bondholders' Blessing For More
Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.
Moberg Adds DermoPlast Line With Bondholders' Blessing For More
Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.
Taking GSK's Consumer Helm Gives McNamara View From Atop The OTC Space
Brian McNamara becomes GSK Consumer CEO after Emma Walmsley is named to succeed Andrew Witty in 2017 to run Glaxo.